FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.
Published July 20, 2016 · Recall initiated: April 20, 2016
Summary
FDA records drug Class II recall D-1347-2016, published July 20, 2016 and initiated April 20, 2016. Recalling firm: Murray International Trading Co., Inc.; Status: Terminated; Reported quantity: unknown; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Murray International Trading Co., Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- All lots
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA"Herbal Doctor" brand Angelicae Sinensis, Natural Herb, Net Wt. 16 oz (454 g) packaged in a green plastic bag;December 8, 2021
- FDAFUQINGSONG RELIEF CREAM (Flucinonide Ointment), packaged in 50-count individually labeled pieces Net Wt.July 20, 2016
- FDAGASTRODIA CAPSULES, packaged in 30-count bottles within a box, LANZHOU MANUFACTORY OF CHINA. GANSU CHINA;July 20, 2016
- FDAFARSER KAI YEUNG PILL, packaged in a bottle within a box, Made in The Peoples Republic of China, remainingJuly 20, 2016
- FDAChingChunBao ANTI-AGING TABLETS, packaged in 80-count bottles within a box, UPC 0 49987 01144 9, remainingJuly 20, 2016
- FDACROCODILE BILE PILL FOR ASTHMA, packaged in 100-count bottles within a box, remaining labeling containsJuly 20, 2016
Questions about this recall
Was FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters. recalled?
Yes. FDA published recall D-1347-2016 on July 20, 2016. Reported hazard: Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone